Uwe Koppe

1.3k total citations
36 papers, 865 citations indexed

About

Uwe Koppe is a scholar working on Infectious Diseases, Epidemiology and Sociology and Political Science. According to data from OpenAlex, Uwe Koppe has authored 36 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 17 papers in Epidemiology and 12 papers in Sociology and Political Science. Recurrent topics in Uwe Koppe's work include HIV/AIDS Research and Interventions (17 papers), HIV, Drug Use, Sexual Risk (11 papers) and Sex work and related issues (8 papers). Uwe Koppe is often cited by papers focused on HIV/AIDS Research and Interventions (17 papers), HIV, Drug Use, Sexual Risk (11 papers) and Sex work and related issues (8 papers). Uwe Koppe collaborates with scholars based in Germany, United Kingdom and Sweden. Uwe Koppe's co-authors include Norbert Suttorp, Bastian Opitz, Birgitt Gutbier, Martin Witzenrath, Tim Eckmanns, Ines Noll, Viviane Bremer, Karolin Meixenberger, Guido Werner and D. Lorenz and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cell Death and Differentiation.

In The Last Decade

Uwe Koppe

34 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Uwe Koppe Germany	12	352	275	275	184	114	36	865
David Lakey United States	18	432 1.2×	186 0.7×	281 1.0×	579 3.1×	48 0.4×	45	1.0k
Giulia Ciccarese Italy	21	534 1.5×	131 0.5×	93 0.3×	248 1.3×	124 1.1×	100	1.2k
Katharine Darling Switzerland	21	583 1.7×	124 0.5×	65 0.2×	758 4.1×	53 0.5×	76	1.5k
Wolfgang Poeppl Austria	19	344 1.0×	140 0.5×	83 0.3×	332 1.8×	209 1.8×	61	1.0k
Maile Karris United States	17	374 1.1×	244 0.9×	79 0.3×	600 3.3×	50 0.4×	62	1.2k
Dawn Nolt United States	17	419 1.2×	84 0.3×	189 0.7×	360 2.0×	73 0.6×	34	795
E L Pesanti United States	25	1.1k 3.2×	123 0.4×	274 1.0×	609 3.3×	119 1.0×	52	1.7k
Benjamin Lee United States	20	366 1.0×	129 0.5×	299 1.1×	453 2.5×	38 0.3×	44	1.0k
Yanri Wijayanti Subronto Indonesia	15	557 1.6×	116 0.4×	163 0.6×	658 3.6×	24 0.2×	51	911

Countries citing papers authored by Uwe Koppe

Since Specialization

Citations

This map shows the geographic impact of Uwe Koppe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Koppe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Koppe more than expected).

Fields of papers citing papers by Uwe Koppe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Koppe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Koppe. The network helps show where Uwe Koppe may publish in the future.

Co-authorship network of co-authors of Uwe Koppe

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Koppe. A scholar is included among the top collaborators of Uwe Koppe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Koppe. Uwe Koppe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koppe, Uwe, et al.. (2025). HIV Testing and PrEP Use Among Trans and/or Non-binary Participants in the TASG Study, a Participatory Study in Germany. AIDS and Behavior. 29(5). 1608–1618. 1 indexed citations

Koppe, Uwe, et al.. (2024). Clinically inapparent mpox virus (MPXV) infections among clients of three anonymous Community Based Voluntary Counselling and Testing centres in Berlin, Germany, 2022–2023. BMC Infectious Diseases. 24(1). 613–613. 3 indexed citations

Krings, Amrei, Christian Kollan, Daniel Schmidt, et al.. (2024). Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999–2023). Infection. 53(3). 1013–1028.

Behrens, Georg M. N., Markus Bickel, Christoph Boesecke, et al.. (2024). Prevalence of HIV in people with potential HIV-indicator conditions in Germany: an analysis of data from statutory health insurances. EClinicalMedicine. 73. 102694–102694. 1 indexed citations

Hanke, Kirsten, et al.. (2024). Developing a next level integrated genomic surveillance: Advances in the molecular epidemiology of HIV in Germany. International Journal of Medical Microbiology. 314. 151606–151606. 1 indexed citations

Kessel, Johanna, Tilman Lingscheid, Jan Grothe, et al.. (2024). Survival after cryptococcosis in Germany: A retrospective multicenter cohort study of patients diagnosed between 2004 and 2021. International Journal of Medical Microbiology. 314. 151614–151614. 1 indexed citations

Sperle, Ida, Uwe Koppe, Raskit Lachmann, et al.. (2023). COVID-19 cross-border case and contact tracing activities - experiences and lessons learnt, Germany, April-December 2020. BMC Public Health. 23(1). 1288–1288. 1 indexed citations

Kollan, Christian, Barbara Gunsenheimer‐Bartmeyer, Björn‐Erik Ole Jensen, et al.. (2023). AIDS in the era of antiretroviral therapy: Changes in incidence rates and predictors of AIDS among people living with HIV under clinical care in Germany, a cohort study 1999–2018. HIV Medicine. 24(7). 794–806.

Fiebig, Uwe, Andrea Hauser, Uwe Koppe, et al.. (2023). Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020. BMC Infectious Diseases. 23(1). 673–673. 4 indexed citations

10.

Marcus, Ulrich, Daniel Schmidt, Susanne Schink, & Uwe Koppe. (2022). Analysis of HIV pre-exposure prophylaxis (PrEP) needs and PrEP use in Germany among men who have sex with men. Journal of Public Health. 31(9). 1505–1521. 9 indexed citations

11.

Koppe, Uwe, Ulrich Marcus, Stefan Albrecht, et al.. (2021). Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany. BMC Public Health. 21(1). 159–159. 27 indexed citations

12.

Koppe, Uwe, Hendrik Wilking, Thomas Harder, et al.. (2021). COVID-19-Patientinnen und -Patienten in Deutschland: Expositionsrisiken und assoziierte Faktoren für Hospitalisierungen und schwere Krankheitsverläufe. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 64(9). 1107–1115. 9 indexed citations

13.

Hickson, Ford, et al.. (2020). Sexual and Mental Health Inequalities across Gender Identity and Sex-Assigned-at-Birth among Men-Who-Have-Sex-with-Men in Europe: Findings from EMIS-2017. International Journal of Environmental Research and Public Health. 17(20). 7379–7379. 16 indexed citations

14.

Hauser, Andrea, Matthias an der Heiden, Karolin Meixenberger, et al.. (2019). Evaluation of a BioRad Avidity assay for identification of recent HIV-1 infections using dried serum or plasma spots. Journal of Virological Methods. 266. 114–120. 6 indexed citations

15.

Markwart, Robby, Niklas Willrich, Sebastian Haller, et al.. (2019). The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS). Antimicrobial Resistance and Infection Control. 8(1). 147–147. 88 indexed citations

16.

Koppe, Uwe, Dorothea Nitsch, Kathryn E. Mansfield, et al.. (2018). Long-term effects of bariatric surgery on acute kidney injury: a propensity-matched cohort in the UK Clinical Practice Research Datalink. BMJ Open. 8(5). e020371–e020371. 9 indexed citations

17.

Koppe, Uwe, Lars Eric Kroll, Ines Noll, et al.. (2018). Carbapenem non-susceptibility of Klebsiella pneumoniae isolates in hospitals from 2011 to 2016, data from the German Antimicrobial Resistance Surveillance (ARS). Antimicrobial Resistance and Infection Control. 7(1). 71–71. 32 indexed citations

18.

Pittrow, David, Jens Klotsche, Michael Kreuter, et al.. (2014). Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practice: Insights-Ipf Registry. Value in Health. 17(7). A600–A600. 7 indexed citations

19.

Lauber, Kirsten, Hildegard Keppeler, Luis E. Muñoz, et al.. (2013). Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids. Cell Death and Differentiation. 20(9). 1230–1240. 58 indexed citations

20.

Koppe, Uwe, Norbert Suttorp, & Bastian Opitz. (2011). Recognition of Streptococcus pneumoniae by the innate immune system. Cellular Microbiology. 14(4). 460–466. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact